Enzo Biochem, Inc. ($0.01 Par Value) (ENZ): Price and Financial Metrics


Enzo Biochem, Inc. ($0.01 Par Value) (ENZ): $3.27

0.01 (+0.31%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ENZ POWR Grades


  • ENZ scores best on the Growth dimension, with a Growth rank ahead of 94.24% of US stocks.
  • The strongest trend for ENZ is in Growth, which has been heading up over the past 31 weeks.
  • ENZ's current lowest rank is in the Sentiment metric (where it is better than 31.06% of US stocks).

ENZ Stock Summary

  • ENZ's went public 35.6 years ago, making it older than 92.76% of listed US stocks we're tracking.
  • With a price/earnings ratio of 117.97, Enzo Biochem Inc P/E ratio is greater than that of about 93.11% of stocks in our set with positive earnings.
  • Revenue growth over the past 12 months for Enzo Biochem Inc comes in at 45.25%, a number that bests 87.77% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to Enzo Biochem Inc, a group of peers worth examining would be IOSP, FEIM, CWCO, PPSI, and FARO.
  • ENZ's SEC filings can be seen here. And to visit Enzo Biochem Inc's official web site, go to www.enzo.com.

ENZ Valuation Summary

  • ENZ's price/sales ratio is 1.3; this is 63.89% lower than that of the median Healthcare stock.
  • Over the past 243 months, ENZ's price/sales ratio has gone down 12.2.
  • Over the past 243 months, ENZ's price/earnings ratio has gone up 3.1.

Below are key valuation metrics over time for ENZ.

Stock Date P/S P/B P/E EV/EBIT
ENZ 2015-09-14 1.4 4.0 -9.9 -9.2
ENZ 2015-01-13 1.7 4.7 -15.4 -14.6
ENZ 2013-07-29 0.9 2.4 -2.0 -1.8
ENZ 2012-05-16 0.8 1.0 -5.3 -4.8
ENZ 2011-04-01 1.6 1.7 -9.4 -9.0
ENZ 2001-08-10 13.8 8.5 118.5 63.6

ENZ Stock Price Chart Interactive Chart >

Price chart for ENZ

ENZ Price/Volume Stats

Current price $3.27 52-week high $4.85
Prev. close $3.26 52-week low $1.80
Day low $3.26 Volume 111,076
Day high $3.35 Avg. volume 859,714
50-day MA $3.11 Dividend yield N/A
200-day MA $2.87 Market Cap 158.50M

Enzo Biochem, Inc. ($0.01 Par Value) (ENZ) Company Bio


Enzo Biochem, Inc. engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company was founded in 1976 and is based in New York, New York.


ENZ Latest News Stream


Event/Time News Detail
Loading, please wait...

ENZ Latest Social Stream


Loading social stream, please wait...

View Full ENZ Social Stream

Latest ENZ News From Around the Web

Below are the latest news stories about Enzo Biochem Inc that investors may wish to consider to help them evaluate ENZ as an investment opportunity.

ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR RAPID EXTRACTION METHOD ON PROPRIETARY TEST SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2

NEW YORK, NY, July 20, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, announced today that it has received an expansion of its FDA Emergency Use Authorization (EUA) for the Company’s rapid extraction method on its proprietary test system for the detection of coronavirus SARS-CoV-2 including the genetic variants that are now proliferating globally. The EUA enables laboratories to immediately use Enzo’s faster extrac

Yahoo | July 20, 2021

Does Enzo Biochem (NYSE:ENZ) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Yahoo | July 14, 2021

Enzo Biochem Announces Online Service with TrustAssure to Schedule Timely PCR Testing Required for International Travel

Testing will be available through CLX Healths TrustAssure Global Testing Platform for international travelers from New York and New Jersey who will need to complete testing immediately prior to travel.

Intrado Digital Media | June 15, 2021

Enzo Biochem Reports Third Quarter Fiscal 2021 Results

Conference call and live webcast scheduled for today, Wednesday, June 9, 2021 at 4:30 PM (ET).

Intrado Digital Media | June 9, 2021

Enzo Biochem to Report Third Quarter 2021 Financial Results on Wednesday, June 9

Conference Call and Webcast Scheduled for June 9, 2021, 4:30 pm ET Conference Call and Webcast Scheduled for June 9, 2021, 4:30 pm ET

GlobeNewswire | June 1, 2021

Read More 'ENZ' Stories Here

ENZ Price Returns

1-mo 2.19%
3-mo 11.99%
6-mo 9.73%
1-year 37.39%
3-year -27.01%
5-year -51.56%
YTD 29.76%
2020 -4.18%
2019 -5.40%
2018 -65.89%
2017 17.44%
2016 54.22%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8749 seconds.